The extent and burden of high multimorbidity on older adults in the US: a descriptive analysis of Medicare beneficiaries.
Aging
Epidemiology
Longitudinal analysis
Multimorbidity
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
received:
13
03
2024
accepted:
23
08
2024
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
20
9
2024
Statut:
epublish
Résumé
The impact of multimorbidity (≥ 2 chronic diseases) on the well-being of older adults is substantial but variable. The burden of multimorbidity varies by the number and kinds of conditions, and timing of onset. The impact varies by age, race, ethnicity, socioeconomic status, and health indicators. Large scale longitudinal surveys linked to medical claims provide unique opportunities to characterize this variability. We analyzed Medicare-linked Health and Retirement Study data for respondents 65 and older with 3 or more years of fee-for-service coverage (n = 17,199; 2000-2016). We applied standardized claims algorithms for operationalizing 21 chronic diseases. We compared multimorbidity levels, demographics, and outcomes at baseline and over time and escalation to high multimorbidity levels (≥ 5 conditions). At baseline, 51.2% had no multimorbidity, 36.5% had multimorbidity, and 12.4% had high multimorbidity. Loss of function, cognitive decline, and higher healthcare utilization were up to ten times more prevalent in the high multimorbidity group. Greater rates of high multimorbidity were seen among non-Hispanic Black and Hispanic groups, those with lower wealth, younger birth cohorts, and adults with obesity. Rates of transition to high multimorbidity varied greatly and was highest among Hispanic and respondents with lower education. The development and progression of multimorbidity in old age is influenced by many factors. Higher levels of multimorbidity are associated with sociodemographic characteristics, suggesting possible mitigation strategies.
Sections du résumé
BACKGROUND
BACKGROUND
The impact of multimorbidity (≥ 2 chronic diseases) on the well-being of older adults is substantial but variable. The burden of multimorbidity varies by the number and kinds of conditions, and timing of onset. The impact varies by age, race, ethnicity, socioeconomic status, and health indicators. Large scale longitudinal surveys linked to medical claims provide unique opportunities to characterize this variability.
METHODS
METHODS
We analyzed Medicare-linked Health and Retirement Study data for respondents 65 and older with 3 or more years of fee-for-service coverage (n = 17,199; 2000-2016). We applied standardized claims algorithms for operationalizing 21 chronic diseases. We compared multimorbidity levels, demographics, and outcomes at baseline and over time and escalation to high multimorbidity levels (≥ 5 conditions).
RESULTS
RESULTS
At baseline, 51.2% had no multimorbidity, 36.5% had multimorbidity, and 12.4% had high multimorbidity. Loss of function, cognitive decline, and higher healthcare utilization were up to ten times more prevalent in the high multimorbidity group. Greater rates of high multimorbidity were seen among non-Hispanic Black and Hispanic groups, those with lower wealth, younger birth cohorts, and adults with obesity. Rates of transition to high multimorbidity varied greatly and was highest among Hispanic and respondents with lower education.
CONCLUSIONS
CONCLUSIONS
The development and progression of multimorbidity in old age is influenced by many factors. Higher levels of multimorbidity are associated with sociodemographic characteristics, suggesting possible mitigation strategies.
Identifiants
pubmed: 39304796
doi: 10.1186/s12877-024-05329-y
pii: 10.1186/s12877-024-05329-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
777Informations de copyright
© 2024. The Author(s).
Références
Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J. Multiple Chronic Conditions Chartbook. AHRQ Publications No, Q14-0038. Rockville: Agency for Healthcare Research and Quality; 2014.
Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity Nat Rev Dis Primers. 2022;8(1):48.
doi: 10.1038/s41572-022-00376-4
pubmed: 35835758
Zhou X, Zhang D. Multimorbidity in the Elderly: A Systematic Bibliometric Analysis of Research Output. Int J Environ Res Public Health. 2021;19(1):353.
doi: 10.3390/ijerph19010353
pubmed: 35010613
pmcid: 8744847
Bricca A, Jäger M, Johnston M, Zangger G, Harris LK, Midtgaard J, et al. Effect of In-Person Delivered Behavioural Interventions in People with Multimorbidity: Systematic Review and Meta-analysis. Int J Behav Med. 2023;30:167–89.
Fortin M, Stewart M, Almirall J, Beaupré P. Challenges in Multimorbidity Research: Lessons Learned From the Most Recent Randomized Controlled Trials in Primary Care. Front Med (Lausanne). 2022;9: 815783.
doi: 10.3389/fmed.2022.815783
pubmed: 35280865
Quiñones AR, Nagel CL, Botoseneanu A, Newsom JT, Dorr DA, Kaye J, et al. Multidimensional trajectories of multimorbidity, functional status, cognitive performance, and depressive symptoms among diverse groups of older adults. J Multimorb Comorb. 2022;12:26335565221143012.
doi: 10.1177/26335565221143012
pubmed: 36479143
pmcid: 9720836
Schiøtz ML, Stockmarr A, Høst D, Glümer C, Frølich A. Social disparities in the prevalence of multimorbidity - A register-based population study. BMC Public Health. 2017;17(1):422.
doi: 10.1186/s12889-017-4314-8
pubmed: 28486983
pmcid: 5424300
Bendayan R, Zhu Y, Federman AD, Dobson RJB. Multimorbidity Patterns and Memory Trajectories in Older Adults: Evidence From the English Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2021;76(5):867–75.
doi: 10.1093/gerona/glab009
pubmed: 33449072
pmcid: 8087269
Thygesen LC, Christensen K, Rørth M, Sørensen HT, Vandenbroucke JP, Westendorp RGJ. Tipping Points - Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? Clin Epidemiol. 2021;13:853–7.
doi: 10.2147/CLEP.S325348
pubmed: 34588816
pmcid: 8473562
Quiñones AR, Botoseneanu A, Markwardt S, Nagel CL, Newsom JT, Dorr DA, et al. Racial/ethnic differences in multimorbidity development and chronic disease accumulation for middle-aged adults. PLoS ONE. 2019;14(6): e0218462.
doi: 10.1371/journal.pone.0218462
pubmed: 31206556
pmcid: 6576751
Canizares M, Hogg-Johnson S, Gignac MAM, Glazier RH, Badley EM. Increasing Trajectories of Multimorbidity Over Time: Birth Cohort Differences and the Role of Changes in Obesity and Income. J Gerontol B Psychol Sci Soc Sci. 2018;73(7):1303–14.
doi: 10.1093/geronb/gbx004
pubmed: 28199711
Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE. 2014;9(7):e102149.
doi: 10.1371/journal.pone.0102149
pubmed: 25048354
pmcid: 4105594
Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018;42(2):186–94.
doi: 10.1111/1753-6405.12762
pubmed: 29442409
Wagner C, Carmeli C, Chiolero A, Cullati S. Life course socioeconomic conditions and multimorbidity in old age - A scoping review. Ageing Res Rev. 2022;78: 101630.
doi: 10.1016/j.arr.2022.101630
pubmed: 35430301
Head A, Fleming K, Kypridemos C, Schofield P, Pearson-Stuttard J, O’Flaherty M. Inequalities in incident and prevalent multimorbidity in England, 2004–19: a population-based, descriptive study. The Lancet Healthy Longevity. 2021;2(8):e489–97.
doi: 10.1016/S2666-7568(21)00146-X
pubmed: 36097998
Bishop NJ, Haas SA, Quiñones AR. Cohort Trends in the Burden of Multiple Chronic Conditions Among Aging U.S. Adults. J Gerontol B Psychol Sci Soc Sci. 2022;77:1867–79.
Liu H, Zhang X, Chen B, Fang B, Lou VWQ, Hu J. The Differential Impact of Multimorbidity Patterns and Subsequent Accumulation on Longitudinal Trajectories of Physical Function Decline in a Population-based Cohort of Older People. J Gerontol A Biol Sci Med Sci. 2022;77:1629–36.
Chronic Conditions Data Warehouse. Centers for Medicare and Medicaid Services. Available from: https://www2.ccwdata.org/condition-categories .
Schneider KM, O’Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Outcomes. 2009;7:82.
doi: 10.1186/1477-7525-7-82
pubmed: 19737412
pmcid: 2748070
Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75–83.
doi: 10.1093/epirev/mxs009
pubmed: 23372025
Boyd CM, Fortin M. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? Public Health Rev. 2010;32(2):451–74.
doi: 10.1007/BF03391611
Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and Practice. Prev Chronic Dis. 2013;10:E66.
doi: 10.5888/pcd10.120239
pubmed: 23618546
pmcid: 3652713
U.S. Department of Health and Human Services. Multiple Chronic Conditions—A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions. Washington: 2010.
Langa KM, Weir DR, Kabeto M, Sonnega A. Langa-Weir Classification of Cognitive Function (1995 Onward). Ann Arbor: Survey Research Center, Institute for Social Research, University of Michigan; 2020.
Barosso G. How to Identify Hospital Claims for Emergency Room Visits in the Medicare Claims Data: Research Data Assistance Center; [updated 07/30/2015. Available from: https://resdac.org/articles/how-identify-hospital-claims-emergency-room-visits-medicare-claims-data#:~:text=Claims%20in%20the%20Outpatient%20and,Professional%20fees%2DEmergency%20room )
Wolinsky FD, Jones MP, Ullrich F, Lou Y, Wehby GL. The concordance of survey reports and Medicare claims in a nationally representative longitudinal cohort of older adults. Med Care. 2014;52(5):462–8.
doi: 10.1097/MLR.0000000000000120
pubmed: 24714584
Griffith LE, Gilsing A, Mangin D, Patterson C, van den Heuvel E, Sohel N, et al. Multimorbidity Frameworks Impact Prevalence and Relationships with Patient-Important Outcomes. J Am Geriatr Soc. 2019;67(8):1632–40.
doi: 10.1111/jgs.15921
pubmed: 30957230
Johnston KJ, Hammond G, Meyers DJ, Joynt Maddox KE. Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures. JAMA. 2021;326(7):628–36.
doi: 10.1001/jama.2021.10413
pubmed: 34402828
Park S, Werner RM, Coe NB. Racial and ethnic disparities in access to and enrollment in high-quality Medicare Advantage plans. Health Serv Res. 2023;58(2):303–13.
doi: 10.1111/1475-6773.13977
pubmed: 35342936
Agarwal R, Connolly J, Gupta S, Navathe AS. Comparing Medicare Advantage And Traditional Medicare: A Systematic Review. Health Aff (Millwood). 2021;40(6):937–44.
doi: 10.1377/hlthaff.2020.02149
pubmed: 34097516
Suls J, Bayliss EA, Berry J, Bierman AS, Chrischilles EA, Farhat T, et al. Measuring Multimorbidity: Selecting the Right Instrument for the Purpose and the Data Source. Med Care. 2021;59(8):743–56.
doi: 10.1097/MLR.0000000000001566
pubmed: 33974576
pmcid: 8263466
Hajat C, Siegal Y, Adler-Waxman A. Clustering and Healthcare Costs With Multiple Chronic Conditions in a US Study. Front Public Health. 2020;8: 607528.
doi: 10.3389/fpubh.2020.607528
pubmed: 33553094